The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition

Wang Maoli; Wu Kejin; Zhang Peng; Zhang Mingdi; Ding Ang; Chen Hongliang

首页> 外文期刊>Annals of surgical oncology >The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition

【24h】

The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition

机译：基于更新AJCC第8版的预后阶段的T1-2N1M0雌激素受体阳性HER2阴性乳腺癌癌型DX复发评分的预后意义

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. This study aimed to evaluate the prognostic significance of the Oncotype DX recurrence score (RS) in T1-2N1M0 estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer based on the prognostic stage in the updated American Joint Commission on Cancer, 8th edition.

机译：背景。本研究旨在评估T1-2N1M0雌激素受体（ER） - 阳性，人体表皮生长因子受体2（HER2） - 在更新的预后阶段的人体表皮生长因子受体2（HER2）中的癌型DX复发评分（RS）的预后意义美国癌症联合委员会第8版。

著录项

来源
《Annals of surgical oncology 》 |2019年第5期| 共9页
作者
Wang Maoli; Wu Kejin; Zhang Peng; Zhang Mingdi; Ding Ang; Chen Hongliang;
展开▼
作者单位

Fudan Univ Dept Breast Surg Obstet &

Gynecol Hosp Shanghai Peoples R China;

Fudan Univ Dept Breast Surg Obstet &

Gynecol Hosp Shanghai Peoples R China;

Fudan Univ Dept Breast Surg Obstet &

Gynecol Hosp Shanghai Peoples R China;

Fudan Univ Dept Breast Surg Obstet &

Gynecol Hosp Shanghai Peoples R China;

Fudan Univ Dept Breast Surg Obstet &

Gynecol Hosp Shanghai Peoples R China;

Fudan Univ Dept Breast Surg Obstet &

Gynecol Hosp Shanghai Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. 基于上皮-间质转化标志物的循环肿瘤细胞表型检测对HER2阴性转移性乳腺癌一线化疗的预后意义 [J] . Xiuwen Guan, Ruigang Cai, Ying Fan, 癌症（英文版） . 2019 ,第009期
2. The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition [J] . Wang Maoli, Wu Kejin, Zhang Peng, Annals of surgical oncology . 2019 ,第5期

机译：基于更新AJCC第8版的预后阶段的T1-2N1M0雌激素受体阳性HER2阴性乳腺癌癌型DX复发评分的预后意义
3. The American Joint Commission Cancer 8th Edition Prognostic Stage Including Oncotype DX? Recurrence Score: Impact on Staging of Early Breast Cancer [J] . Roisin O’Cearbhaill, John?M. Gannon, Ruth?S. Prichard, Pathobiology: journal of immunopathology, molecular and cellular biology . 2019 ,第2a3期

机译：美国联合委员会癌症第8版预后阶段包括Oncotype DX？复发评分：对早期乳腺癌分期的影响
4. Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer. [J] . Yorozuya K, Takeuchi T, Yoshida M, Journal of Cancer Research and Clinical Oncology . 2010 ,第6期

机译：在日本女性中，雌激素受体阳性，淋巴结阴性的原发性I或IIA乳腺癌患者评估Oncotype DX复发评分作为预后因素。
5. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
6. Prognostic significance of some clinical, histopathological and biological parameters for survival of node-negative breast cancer patients treated in University Medical centre Maribor in the period 2000-2009 [D] . Fokter Dovnik, Nina. 2017

机译：2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床，组织病理学和生物学参数的预后意义
7. Comparison of Pathological Prognostic Stage and Anatomic Stage Groups According to the Updated Version of the American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8th Edition [O] . Kamuran Ibis, Selnur Ozkurt, Seden Kucucuk, 1923

机译：根据美国癌症联合委员会（AJCC）乳腺癌分期第8版的更新版本，比较病理预后阶段和解剖阶段组
8. Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study [O] . Miguel Martin, Jan C. Brase, Amparo Ruiz, 2016

机译：与基于研究的版本的PAM50淋巴结阳性，雌激素受体阳性和HER2阴性乳腺癌的复发风险（ROR）评分相比，EndoPredict的预后能力。 GEICAM / 9906子研究

The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition

摘要

著录项

相似文献

相关主题

期刊订阅